Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Long-Term Investments: 2021-2022

Historic Long-Term Investments for Cullinan Therapeutics (CGEM) over the last 2 years, with Dec 2022 value amounting to $80.9 million.

  • Cullinan Therapeutics' Long-Term Investments fell 49.51% to $15.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $15.5 million, marking a year-over-year decrease of 49.51%. This contributed to the annual value of $80.9 million for FY2022, which is 42.39% down from last year.
  • According to the latest figures from FY2022, Cullinan Therapeutics' Long-Term Investments is $80.9 million, which was down 42.39% from $140.4 million recorded in FY2021.
  • In the past 5 years, Cullinan Therapeutics' Long-Term Investments ranged from a high of $140.4 million in FY2021 and a low of $80.9 million during FY2022.
  • Its 2-year average for Long-Term Investments is $110.6 million, with a median of $110.6 million in 2021.
  • Data for Cullinan Therapeutics' Long-Term Investments shows a maximum YoY plummeted of 42.39% (in 2022) over the last 5 years.
  • Over the past 2 years, Cullinan Therapeutics' Long-Term Investments (Yearly) stood at $140.4 million in 2021, then plummeted by 42.39% to $80.9 million in 2022.